United States· US:24208-023_41d745af-7d7b-dc08-e063-6394a90a2fbf
Methazolamide
A methazolamide product containing methazolamide, registered in United States by Bausch & Lomb Incorporated. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Methazolamide is registered in 3 of 19 countries.
Countries holding a registration under ATC S01EC05 (methazolamide), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Methazolamide · ATC S01EC05
3 / 19 countries
- Canada
- Norwayprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- METHAZOLAMIDE
- Manufacturer
- Bausch & Lomb Incorporated
- Country
- United States (US)
- ATC code
- S01EC05
- ATC class
- Methazolamide
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 8
- ndc1124208023011000 TABLET in 1 BOTTLE (24208-023-01)
- ndc112420802310100 TABLET in 1 BOTTLE (24208-023-10)
- ndc112420802350500 TABLET in 1 BOTTLE (24208-023-50)
- ndc11242080239090 TABLET in 1 BOTTLE (24208-023-90)
- ndc1124208-023-01
- ndc1124208-023-10
- ndc1124208-023-50
- ndc1124208-023-90
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
138 interactions on record for methazolamide.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Methazolamide · interactions on record
138 records
- 7 severe
- 126 moderate
- 5 minor
Most severe, free to view
- CisaprideA03FA02severe
- MetforminA10BA02severe
- Acetylsalicylic acidB01AC06severe
- Salicylic acidD01AE12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Methazolamide in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/affb7d4c-ee20-469a-823b-fb6143809aaf GET /v1/drugs/affb7d4c-ee20-469a-823b-fb6143809aaf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "50",
"substance": "METHAZOLAMIDE",
"productndc": "24208-023",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA207438",
"marketing_category": "ANDA"
}See everything about methazolamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.